Wikipedia -WSS

Wikipedia

author：focus 2025-09-06 04:38:37 - browse：3

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

focus

WSS

Pope Francis asks Church to identify 21st

5 shark bites reported on Long Island as officials deploy surveillance drones

U.K. officials, researchers try to ease path for bespoke genetic treatments

Bring on the sabbaticals for nurses

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Affirmative action in medical school literally saved lives

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

How to save PrEP access — and even expand it

Bring on the sabbaticals for nurses

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

6 surprising facts about sugar

Medicare details structure of new drug price negotiation program

Israel withdraws forces after 2

BioMarin wins approval for gene therapy to treat hemophilia A

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

leisure time

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Medical devices makers are asking for forgiveness, not permission

Bring on the sabbaticals for nurses

Former New York Mayor de Blasio and wife announce separation, but not divorce

Medical devices makers are asking for forgiveness, not permission

2 million sign

explore

entertainment

focus

Wikipedia